The Asia Pacific Healthcare Group (APHG) have added further clinical representation to its Executive Leadership Team by appointing Dr Richard Steele, a clinical immunologist and immunopathologist based in Wellington. 

APHG Chief Executive Anoop Singh says, “APHG employ more scientific staff and pathologists than any other laboratory provider in the country. By appointing Dr Steele to the APHG Executive we’re ensuring that we have another strong, clinical voice at the table. The expertise of this part of our workforce should always be a strong contributor to the direction of our business.

“We’ve tasked Richard with establishing a leadership group for APHG’s clinical pathologists, who together will co-design and implement a strategic operating model which is aligned to the Health NZ landscape.

“Richard has extensive experience in laboratory services both here in Aotearoa and in Australia. He’s the perfect fit for the role, which ultimately will make a real difference to patient outcomes.”

Dr Richard Steele has previously been Medical Director of Wellington SCL, and the New Zealand Vice President of the College of Pathologists Australasia.

He has experience in all aspects of clinical immunology and immunopathology including allergy, autoimmune diseases, primary immunodeficiency and HIV. Dr Steele has a particular interest in autoimmune disease including coeliac disease, neuroimmunology and quality assurance.

He is currently an examiner for the Royal Australasian College of Pathologists and also sits on the Medical Technical Advisory Committee for IANZ. He holds academic positions with the University of Otago (clinical lecturer) and Victoria University Wellington (Adjunct Professor).

You can meet the other members of our Executive Team here.